← FDA Drug Approvals (Drugs@FDA)

EMPAGLIFLOZIN

NDA · New Drug Application · Sponsor: RIDHISIDHI, PLLC · Approved 2026-09-17

Drug application

FDA Application #

NDA220758

Application type

New Drug Application

Brand name

EMPAGLIFLOZIN

Generic name

Empagliflozin

Active ingredients

EMPAGLIFLOZIN

Dosage form

SOLUTION

Route

—

Marketing status

None (Tentative Approval)

Sponsor

RIDHISIDHI, PLLC

First approval

2026-09-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown